ESLA earnings: a positive outcome, +8.8%

+8.8%Estrella Immunopharma, Inc. (ESLA) →

On November 20, 2023, Estrella Immunopharma, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.8% in the window around the event. It had already run -9.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.25

1d before

$1.36

Event day

$1.40

1d after

$1.41

5d after

Pre-catalyst setup

-9.2%

30-day run-up

7625%

30-day volatility

0.2×

volume spike

ESLA catalyst calendar More earningss Prediction track record Full catalyst calendar